Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a 11.426% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a) CCOC(=O)c1ccc[n+](CC(=O)c2ccccc2)c1.[Br-]
b) CC(C)N1CC(C(=O)Nc2ccccc2)CC1=O
c) CN(C)c1ccnc2sc(C(=O)NCc3ccccc3)c(N)c12
Answer: b. CC(C)N1CC(C(=O)Nc2ccccc2)CC1=O
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC(C)N1CC(C(=O)Nc2ccccc2)CC1=O
CC(C)N1CC(C(=O)Nc2ccccc2)CC1=O
5-oxo-N-phenyl-1-propan-2-ylpyrrolidine-3-carboxamide